Previous 10 | Next 10 |
Synthorx (NASDAQ: THOR ) +169% on being acquired by Sanofi. More news on: Synthorx, Inc., XBiotech Inc., ArQule, Inc., Stocks on the move, Read more ...
Would You Add These To Your Penny Stocks To Buy Or Sell List? Just like Santa has a naughty or nice list, traders have a penny stocks to buy or sell list. Or, at the very least a “ penny stocks to buy or avoid” list. No matter what you label it, the idea of creating a list of...
Penny Stocks Are Benefiting Big Off Of This Latest Move In Biotech Over the years, it has been seen that investing in penny stocks has often proven to be highly rewarding. So, there is always going to be a lot of interest in these stocks. However, when it comes to picking penny stocks to bu...
Introduction Before this report, I have written two other Seeking Alpha reports about Acasti Pharma ( ACST ) in 2019, espousing ACST’s profound market opportunity and its leading drug CaPre’s competitive advantages; my first report in June was published when the stock was onl...
Are These Penny Stocks Set To Head Higher This Week? One of the most important things to keep in mind with regards to penny stocks is that it’s possible to generate substantial returns within a short timespan. While that may be true, an investor still needs to conduct thorough researc...
Gainers: Karuna Therapeutics (NASDAQ: KRTX ) +282% More news on: Karuna Therapeutics, Inc., Hermitage Offshore Services Ltd., Eltek Ltd., Stocks on the move, Read more ...
Karuna Therapeutics (NASDAQ: KRTX ) +80% on positive KarXT data . More news on: Karuna Therapeutics, Inc., Eros International Plc, Capstone Turbine Corporation, Stocks on the move, Read more ...
BEDMINSTER, N.J., Nov. 18, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical stage biopharmaceutical company, today announced that Jerome D. Jabbour, Chief Executive Officer, has been invited to present a company overview, as well as host investor meeti...
Acasti Pharma (NASDAQ: ACST ) and Matinas BioPharma Holdings (NYSEMKT: MTNB ) are jumping after hours following Amarin's FDA panel win to expand the label for its heart drug Vascepa. More news on: Acasti Pharma Inc., Matinas BioPharma Holdings, Inc., Healthcare stocks news, Stocks on the...
Matinas BioPharma Holdings, Inc. (MTNB) Q3 2019 Earnings Conference Call November 13, 2019 8:00 AM ET Company Participants Peter Vozzo - Investor Relations Jerry Jabbour - Chief Executive Officer Keith Kucinski - Chief Financial Officer Terry Ferguson - Chief Medical Officer ...
News, Short Squeeze, Breakout and More Instantly...
Matinas Biopharma Holdings Inc. Company Name:
MTNB Stock Symbol:
NYSE Market:
Matinas Biopharma Holdings Inc. Website:
BEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces the recent successful...
BEDMINSTER, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces that MAT2203, its ora...
BEDMINSTER, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces new in vitro data ...